Back
Dermata Therapeutics Vs. Pieris Pharmaceuticals Industry Stock Comparison
Sell
17
DRMA
Dermata Therapeutics
Last Price:
1.76
Seasonality Move:
-51.46%
Sell
31
PIRS
Pieris Pharmaceuticals
Last Price:
16.98
Seasonality Move:
-22.78%
Sell
17
Dermata Therapeutics (DRMA)
is a Sell
Is Dermata Therapeutics a Buy, Sell or Hold?
- The current Dermata Therapeutics [DRMA] share price is $2.25. The Score for DRMA is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- DRMA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
31
Pieris Pharmaceuticals (PIRS)
is a Sell
Is Pieris Pharmaceuticals a Buy, Sell or Hold?
- The current Pieris Pharmaceuticals [PIRS] share price is $16.16. The Score for PIRS is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- PIRS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DRMA Stock Price Chart
What is Dermata Therapeutics's stock price today?
-
The Dermata Therapeutics share price today is $2.25
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRMA is experiencing slight buying pressure.
PIRS Stock Price Chart
What is Pieris Pharmaceuticals's stock price today?
-
The Pieris Pharmaceuticals share price today is $16.16
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PIRS is experiencing selling pressure, which indicates risk of future bearish movement.
DRMA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 58.02 | Buy |
| Chaikin Money Flow: | 245155 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.55 - 2.07) | Buy |
| Bollinger Bands (100): | (1.68 - 3.98) | Sell |
PIRS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.26 | Buy |
| Relative Strength Index (14 RSI): | 45.91 | Sell |
| Chaikin Money Flow: | -3180 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.62 - 18) | Sell |
| Bollinger Bands (100): | (8.84 - 16.36) | Buy |
DRMA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.81 | Buy |
| 20-day SMA: | 1.74 | Buy |
| 50-day SMA: | 2.01 | Buy |
| 200-day SMA: | 5.05 | Sell |
| 8-day EMA: | 1.91 | Buy |
| 20-day EMA: | 1.85 | Buy |
| 50-day EMA: | 2.14 | Buy |
| 200-day EMA: | 9.07 | Sell |
PIRS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.91 | Sell |
| 20-day SMA: | 17.47 | Sell |
| 50-day SMA: | 15.03 | Buy |
| 200-day SMA: | 13.2 | Buy |
| 8-day EMA: | 16.78 | Sell |
| 20-day EMA: | 16.89 | Sell |
| 50-day EMA: | 15.48 | Buy |
| 200-day EMA: | 17.96 | Sell |
Dermata Therapeutics Earnings Growth & DRMA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Pieris Pharmaceuticals Earnings Growth & PIRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $8.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and a decrease next year of $0.09 per share.
Dermata Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Pieris Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||